Department of General Surgery, The Affiliated Wuxi NO.2 People's Hospital of Nanjing Medical University, Wu Xi, Jiangsu, China.
Department of General Surgery, The Affiliated Wuxi NO.2 People's Hospital of Nanjing Medical University, Wu Xi, Jiangsu, China.
Pathol Res Pract. 2020 Dec;216(12):153266. doi: 10.1016/j.prp.2020.153266. Epub 2020 Oct 22.
MicroRNAs (miRNAs) are a group of highly conserved, short (18-25 nucleotide long) non-coding RNAs which play important functional roles in cellular differentiation, biological development, pathogenesis and disease susceptibility and have been linked to both tumorigenesis and the malignant progression of various cancers. miRNAs primarily exert their function through the negative regulation of their target gene's transcription via the specific recognition of their 3' untranslated region. A single miRNA can regulate multiple target genes and most miRNAs are controlled by several factors. Recent studies have shown that microRNA-149 (miR-149) plays a pivotal role in the pathogenesis of digestive system cancers and may act as a potential diagnostic marker and therapeutic target. In this review, we summarize and discuss the most recent reports describing miR-149 in digestive system cancers, including its single nucleotide polymorphisms, expression levels, target genes, drug sensitivity and clinical significance.
MicroRNAs (miRNAs) 是一组高度保守的、短的(18-25 个核苷酸长)非编码 RNA,在细胞分化、生物发育、发病机制和疾病易感性中发挥重要功能作用,与肿瘤发生和各种癌症的恶性进展有关。miRNAs 主要通过特异性识别其 3'非翻译区来负调控其靶基因的转录,从而发挥其功能。单个 miRNA 可以调控多个靶基因,并且大多数 miRNA 受几个因素控制。最近的研究表明,microRNA-149 (miR-149) 在消化系统癌症的发病机制中起着关键作用,并且可能作为一个潜在的诊断标志物和治疗靶点。在这篇综述中,我们总结和讨论了最近关于 miR-149 在消化系统癌症中的报道,包括其单核苷酸多态性、表达水平、靶基因、药物敏感性和临床意义。